SYNTA PHARMACEUTICALS CORP.
Patent Owner
Stats
- 118 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 118 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,894 Total Citation Count
- May 22, 1998 Earliest Filing
- 153 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0340,652 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORSAug 11, 17Nov 30, 17[A61K]
2016/0324,863 TARGETED CANCER TREATMENT BY HSP90 INHIBITORS GANETESPIB AND NVP-AUY922Jan 16, 15Nov 10, 16[A61K, C12Q]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9439899 Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitorsNov 01, 12Sep 13, 16[A61K]
9205086 Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitorApr 19, 11Dec 08, 15[A61K]
9174935 Transition metal complexes of bis[thiohydrazide amide] compoundsOct 21, 09Nov 03, 15[A61K, C07D, C07C, A61P]
9175022 Compounds for the treatment of proliferative disordersAug 01, 13Nov 03, 15[A61K, C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0283,147 TREATING POLYCYSTIC KIDNEY DISEASE WITH HSP90 INHIBITORY COMPOUNDSAbandonedOct 18, 13Oct 08, 15[A61K]
2015/0253,330 PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUSAbandonedOct 15, 14Sep 10, 15[C12Q, G01N]
2015/0119,395 NOVEL TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYAbandonedApr 04, 13Apr 30, 15[C07D]
2015/0099,721 TREATING CANCER WITH HSP90 INHIBITORY COMPOUNDSAbandonedMay 10, 13Apr 09, 15[A61K, C07F, C07D]
2015/0005,320 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedSep 27, 13Jan 01, 15[C07D, C07C]
2014/0363,830 COMPOUNDS THAT MODULATE HSP90 ACTIVITY AND METHODS FOR IDENTIFYING SAMEAbandonedMar 05, 14Dec 11, 14[G01N]
2014/0342,999 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERSAbandonedMay 19, 14Nov 20, 14[A61K, C07C]
2014/0329,892 ADMINISTRATION OF A BIS(THIOHYDRAZIDE AMIDE) COMPOUND FOR TREATING CANCERSAbandonedNov 09, 12Nov 06, 14[A61K, C07C]
2014/0315,943 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MTOR/P13K INHIBITORSAbandonedMay 23, 12Oct 23, 14[A61K, C07D]
2014/0296,176 COMBINATION CANCER THERAPY WITH AN HSP90 INHIBITOR AND AN ANTIMETABOLITEAbandonedAug 17, 12Oct 02, 14[A61K, A61N]
2014/0286,902 COMBINATION THERAPY OF HSP90 INHIBITORS WITH PLATINUM-CONTAINING AGENTSAbandonedNov 01, 12Sep 25, 14[A61K]
2014/0248,299 VINYL-PHENYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 09, 14Sep 04, 14[C07D, C07C]
2014/0242,120 SUBSTITUTED AROMATIC COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 08, 14Aug 28, 14[C07D, C07C]
2014/0228,418 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MEK INHIBITORSAbandonedMay 22, 12Aug 14, 14[A61K]
2014/0194,388 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORSAbandonedMay 25, 12Jul 10, 14[A61K]
2014/0187,586 PYRIDYLPHENYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMar 12, 14Jul 03, 14[C07D]
2014/0178,366 PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT BASED ON HYPOXIC STATUSAbandonedDec 17, 13Jun 26, 14[A61K, G01N, C07K]
2014/0135,331 THIAZOLE AND THIADIAZOLE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 16, 13May 15, 14[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.